Management of Sepsis in Resource Limited Settings Using a Delphi Method.

Sponsor
Oxford University Clinical Research Unit, Vietnam (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05909384
Collaborator
Asia Pacific Sepsis Alliance (Other)
36
1
2
18.3

Study Details

Study Description

Brief Summary

Rapid evolution of sepsis syndromes means that timely diagnosis and treatment are critical in improving outcomes but this may be difficult to achieve in many low- and middle- income countries (LMICs) and there is a lack of high quality clinical evidence to guide diagnosis and management in LMIC settings. The wide variability in health systems in LMICs means that additional areas of guidance may be required where staff or facilities are lacking. In the absence of clinical data, to address some of these issues, the investigators aim to use Delphi methodology to obtain experts consensus statements on some specific aspects of sepsis management in LMICs.

Condition or Disease Intervention/Treatment Phase
  • Other: Survey

Detailed Description

The investigators aim to use a Delphi process to generate expert consensus practice statements in the context of diagnosis and management of sepsis in LMICs, including identification of aspects of sepsis diagnosis and management in LMICs not covered by existing guidelines. The questions will undergo several iterative rounds and will be in multiple-choice or Likert scale format. A study steering group will review the results of each round via video conference and design the questionnaire for the next survey. Summary results of each round will be presented to experts, along with the survey questionnaire for the next round. The survey process will be repeated with the modified questionnaire. The Delphi rounds will continue until the desired consensus and stability are achieved.

Study Design

Study Type:
Observational
Anticipated Enrollment :
36 participants
Observational Model:
Other
Time Perspective:
Other
Official Title:
Expert Consensus Statements for the Management of Sepsis in Resource Limited Settings Using a Delphi Method
Actual Study Start Date :
May 16, 2023
Anticipated Primary Completion Date :
Jul 15, 2023
Anticipated Study Completion Date :
Jul 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Expert group

Clinical expertise in adult sepsis management, AND Demonstrated involvement with sepsis related research, educations, policy/protocols, professional activities

Other: Survey
Multiple rounds of surveys collecting information on sepsis diagnosis and management in resource-limited settings.

Outcome Measures

Primary Outcome Measures

  1. Questionnaire statements which have reached pre-defined consensus [2 weeks]

    Descriptive analysis of questionnaire statements which have reached pre-defined consensus. Consensus will be defined as >70% participants in favour of agree/disagree statements (Likeart scale 1-3 means disagree or 5-7 means agree), or >80% in favour of single option in a single stem question with multiple responses (yes/no answers).

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Recognized experts meeting pre-defined criteria (below) from a wide geographical distribution with approximately 70% from LMICs.
  1. Clinical expertise in adult sepsis management, AND

  2. Demonstrated involvement with sepsis related research, educations, policy/protocols, professional activities

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Oxford University Clinical Research Unit Ho Chi Minh City Vietnam

Sponsors and Collaborators

  • Oxford University Clinical Research Unit, Vietnam
  • Asia Pacific Sepsis Alliance

Investigators

  • Study Director: Brett Abbenbroek, BSc,MPH,PhD, The George Institute

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Oxford University Clinical Research Unit, Vietnam
ClinicalTrials.gov Identifier:
NCT05909384
Other Study ID Numbers:
  • APSADelphi_V1.2
First Posted:
Jun 18, 2023
Last Update Posted:
Jun 18, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Oxford University Clinical Research Unit, Vietnam
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 18, 2023